Navigation Links
TGen Physician-In-Chief Dr. Daniel D. Von Hoff wins ASCO award
Date:4/1/2010

PHOENIX, Ariz. April 1, 2010 Dr. Daniel D. Von Hoff, Physician-in-Chief for the Translational Genomics Research Institute (TGen), has won a top award from the American Society of Clinical Oncology (ASCO) for his cancer research.

Dr. Von Hoff, M.D., F.A.C.P., will receive the 2010 David A. Karnofsky Memorial Award and Lecture at ASCO's 46th Annual Meeting, June 4-8 at the McCormick Place in Chicago.

ASCO will present the award to Dr. Von Hoff "for his outstanding achievements in cancer research and for his impact on the treatment of patients with cancer."

Dr. Von Hoff is an internationally recognized physician-scientist who has contributed to the development of numerous anticancer agents, including paclitaxel, docetaxel, irinotecan and gemcitabine. He also is the Chief Scientific Officer of TGen Clinical Research Services at Scottsdale Healthcare and at US Oncology, and is a Clinical Professor of Medicine at the University of Arizona College of Medicine.

Each year through its Special Awards Program, ASCO recognizes quality researchers, patient advocates and leaders of the global oncology community who through their work have made significant contributions to enhancing cancer care. These recipients of ASCO's highest, most prestigious awards collectively represent significant strides in cancer treatment and leadership in the oncology community.

"The work of this year's awardees collectively represents decades of commitment to improving the care and quality of life for people living with cancer," said Richard L. Schilsky, M.D., ASCO's Immediate Past President and Chair of the Special Awards Selection Committee. "Our understanding of the biological basis of cancer and our ability to transform that knowledge into better treatments for patients have been enhanced by their contributions and it is an honor to present them ASCO's highest awards."

The David A. Karnofsky Memorial Award was first presented in 1970. It recognizes outstanding contributions to cancer research, diagnosis and/or treatment. A lecture is given during the opening session of the ASCO Annual Meeting.

The award is named after David A. Karnofsky, 1914-1969, an American clinical oncologist and specialist in cancer chemotherapy who was affiliated with the Memorial Sloan-Kettering Cancer Center. He is known for developing the Karnofsky scale, an index for determining a patient's suitability for therapy and for estimating a patient's physical state, performance and prognosis after a therapeutic procedure.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. Daniel Simon, MD Urges People with Diabetes to Protect Sight by Getting Diabetic Eye Exam
2. Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball
3. Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009
4. Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure
5. Veteran Journalist Daniel Weintraub Launches HealthyCal.org
6. Pennsylvania EPA Awards Abington Memorial Hospital Funding for Green Projects
7. Carol Milgard Breast Center Awarded Highest Government Rating for Mammography Sites
8. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
9. New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R)
10. Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company
11. UNFPA Honoured With Human Rights Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
Breaking Medicine Technology: